FR2358392A1 - Derives de 2,11-desoxy pge ou pgf, leur procede de preparation et leur application therapeutique - Google Patents

Derives de 2,11-desoxy pge ou pgf, leur procede de preparation et leur application therapeutique

Info

Publication number
FR2358392A1
FR2358392A1 FR7721921A FR7721921A FR2358392A1 FR 2358392 A1 FR2358392 A1 FR 2358392A1 FR 7721921 A FR7721921 A FR 7721921A FR 7721921 A FR7721921 A FR 7721921A FR 2358392 A1 FR2358392 A1 FR 2358392A1
Authority
FR
France
Prior art keywords
derivatives
desoxy
pgf
pge
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7721921A
Other languages
English (en)
French (fr)
Other versions
FR2358392B1 (enrdf_load_stackoverflow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of FR2358392A1 publication Critical patent/FR2358392A1/fr
Application granted granted Critical
Publication of FR2358392B1 publication Critical patent/FR2358392B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/041,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/081,3-Dioxanes; Hydrogenated 1,3-dioxanes condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D339/00Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02Five-membered rings
    • C07D339/06Five-membered rings having the hetero atoms in positions 1 and 3, e.g. cyclic dithiocarbonates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4018Esters of cycloaliphatic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7721921A 1976-07-16 1977-07-18 Derives de 2,11-desoxy pge ou pgf, leur procede de preparation et leur application therapeutique Granted FR2358392A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2632097A DE2632097C2 (de) 1976-07-16 1976-07-16 Cyclopentanderivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel

Publications (2)

Publication Number Publication Date
FR2358392A1 true FR2358392A1 (fr) 1978-02-10
FR2358392B1 FR2358392B1 (enrdf_load_stackoverflow) 1980-02-08

Family

ID=5983219

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7721921A Granted FR2358392A1 (fr) 1976-07-16 1977-07-18 Derives de 2,11-desoxy pge ou pgf, leur procede de preparation et leur application therapeutique

Country Status (13)

Country Link
JP (1) JPS5334754A (enrdf_load_stackoverflow)
AU (1) AU2705677A (enrdf_load_stackoverflow)
BE (2) BE856910A (enrdf_load_stackoverflow)
DE (1) DE2632097C2 (enrdf_load_stackoverflow)
DK (1) DK322177A (enrdf_load_stackoverflow)
ES (1) ES460623A1 (enrdf_load_stackoverflow)
FR (1) FR2358392A1 (enrdf_load_stackoverflow)
GB (1) GB1589525A (enrdf_load_stackoverflow)
IL (1) IL52523A0 (enrdf_load_stackoverflow)
LU (1) LU77767A1 (enrdf_load_stackoverflow)
NL (1) NL7707695A (enrdf_load_stackoverflow)
SE (1) SE7708245L (enrdf_load_stackoverflow)
ZA (2) ZA774254B (enrdf_load_stackoverflow)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2834249A1 (de) * 1978-08-04 1980-02-28 Hoechst Ag Neue prostaglandinderivate in der delta 2-11-desoxy-pgf tief 2 bzw. pge tief 2 -reihe
US20230097470A1 (en) * 2021-08-23 2023-03-30 Chirogate International Inc. Processes and intermediates for the preparations of carboprost and carboprost tromethamine, and carboprost tromethamine prepared therefrom

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
NV134A/77 *
NV2303/74 *

Also Published As

Publication number Publication date
BE856914A (fr) 1978-01-18
ES460623A1 (es) 1978-05-16
GB1589525A (en) 1981-05-13
JPS6218548B2 (enrdf_load_stackoverflow) 1987-04-23
DE2632097A1 (de) 1978-01-19
DK322177A (da) 1978-01-17
JPS5334754A (en) 1978-03-31
AU2705677A (en) 1979-01-18
DE2632097C2 (de) 1985-08-14
IL52523A0 (en) 1977-10-31
SE7708245L (sv) 1978-01-17
ZA774254B (en) 1978-06-28
LU77767A1 (enrdf_load_stackoverflow) 1978-02-08
FR2358392B1 (enrdf_load_stackoverflow) 1980-02-08
BE856910A (fr) 1978-01-18
ZA774255B (en) 1978-06-28
NL7707695A (nl) 1978-01-18

Similar Documents

Publication Publication Date Title
FR2435248A1 (fr) Derives de 4-anilinoquinazoline, leur procede de preparation et leur application en therapeutique
FR2381028A1 (fr) Derives d'acide benzoique, leur procede de preparation et leur application en therapeutique
FR2364219A1 (fr) Derives de thiazolidine, leur procede de preparation et leur application en therapeutique
FR2383187A1 (fr) Derives du cepheme, leur procede de preparation et leur application en therapeutique
FR2372806A1 (fr) Pyrrolidones, leur procede de preparation et leur application therapeutique
FR2400500A1 (fr) Derives d'acides cycloalcoylidenemethylphenylacetiques, leur procede de preparation et leur application en therapeutique
FR2370753A1 (fr) Derives du glucofurannose et leur application therapeutique
FR2405246A1 (fr) Nouveaux derives de pyrrole, leur procede de preparation et leurs applications en therapeutique
FR2422617A1 (fr) Derives polyprenyliques, leur procede de preparation et leur application en therapeutique
FR2384811A1 (fr) Derives de la neocarzinostatine, leur application therapeutique et leur procede de preparation
FR2431494A1 (fr) Nouveaux derives du benzofuranne, leur procede de preparation et leur application en therapeutique
FR2387214A1 (fr) Derives du p-aminomethyl benzene-sulfonamide, leur procede de preparation et leur application therapeutique
FR2358392A1 (fr) Derives de 2,11-desoxy pge ou pgf, leur procede de preparation et leur application therapeutique
FR2421178A1 (fr) Conjugue d'un derive d'acyl-n-acetylmuramyl-peptide et d'un antigene, son procede de preparation et son application therapeutique
FR2355831A1 (fr) Derives de benzazocine, leur procede de preparation et leur application therapeutique
FR2383944A1 (fr) Derives de bis-benzimidazolyle substitues, leur procede de preparation et leur application en therapeutique
FR2398753A1 (fr) Derives de pyranochromone et leur application therapeutique
FR2369260A1 (fr) 2-pyrrolidones 1,5-disubstituees et leurs procedes de preparation
FR2406635A1 (fr) Nouveaux derives du benzo(d)thiazole, leur procede de preparation et leurs applications en therapeutique
FR2392003A1 (fr) Analogues de prostaglandines comprenant un groupement methylene en position 9 et leur preparation
FR2416214A1 (fr) Derives d'acide naphtyl-1 acetique, leur procede de preparation et leur application therapeutique
FR2358393A1 (fr) Derives de 2,11-dexoxy pge, leur procede de preparation et leur application en therapeutique
FR2368489A1 (fr) Derives de la clavuline, leur procede de preparation et leur application en therapeutique
FR2347931A1 (fr) Composition pharmaceutique contenant un inhibiteur de prostaglandine-synthetase et une prostaglandine luteolytique, et son application a la regulation du cycle menstruel
FR2355821A1 (fr) Esters de la 5-methyl-10,11-dihydroprostaglandine-a1, leur procede de preparation et leur application en therapeutique

Legal Events

Date Code Title Description
ST Notification of lapse